One Drop Launches Global Commercial Partnership with Bayer

Vinson & Elkins advised One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, in connection with a $40 million Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world.

Bayer has also entered a commercial licensing agreement to use One Drop’s platform in Bayer’s global bio-digital efforts in therapeutic areas such as oncology, cardiovascular disease and women’s health.

The V&E corporate team was led by partner Paul Tobias and counsel Andy Smetana with assistance from associates Ben Cukerbaum and Vaughn Miller. Also advising was partner Damara Chambers.

For more information, please speak with our media contacts.

Key Contacts

Partner

Paul R. Tobias

+1.512.542.8450

ptobias@velaw.com

Related Insights

V&E⁺

Pioneering a Solution for Debt Holders During a Pandemic

August 10, 2020
The V&E Report

Novartis’ and Alcon’s $345 Million FCPA Case Signals Increased Scrutiny of Gifts and Entertainment and Renewed Focus on Scientific Studies

July 16, 2020
V&E⁺

Smooth Landing: How V&E Helped Southwest Airlines Secure Billions in Funding During the Coronavirus Crisis

June 4, 2020
Insight

4 Takeaways From 3rd Circ. Classwide Antitrust Injury Ruling

Published in Law360

May 6, 2020